These include parathyroid hormone, prostaglandins ... most debilitating problems in patients with cancer. The molecular mechanisms responsible for both osteolytic and osteoblastic metastases ...

Parathyroid hormone may exert its anabolic effect on bone either through a direct stimulatory effect on osteoblastic bone formation or indirectly through a mechanism that requires it to increase ...

Hypoparathyroidism (hypoPT), is one of the rare endocrine disorders that are not routinely managed by hormone replacement as a first-line therapy. In patients with hypoPT, parathyroid hormone (PTH ...

The study disproved a previously untested but widespread belief among bone researchers that combining the two types of drugs—bone-building parathyroid hormone (PTH) and bone resorption inhibiting ...

Hyperparathyroidism is a condition wherein the parathyroid glands create too much parathyroid hormone. This can cause the levels of calcium in the blood to rise, which, without treatment ...

Unfortunately, hyperparathyroidism - when an excess of parathyroid hormone is produced - goes undiagnosed or diagnosed late. This can be because many patients do not showcase apparent symptoms or ...

Hypomagnesemia is associated with hypoparathyroidism (hypoPT) because magnesium is required for efficient synthesis and secretion of parathyroid hormone (PTH). Hypomagnesemia associated with ...

Calcimimetics suppress the secretion of parathyroid hormone by sensitizing the parathyroid calcium receptor to serum calcium. Cinacalcet (Sensipar ® /Mimpara ®, Amgen Inc., Thousand Oaks ...